Onsite Drug Testing

By: Willie Bethune,Erik Syfert📍 United StatesClosed

Key Information

ReferenceGB-70US0926Q70092860
DeadlineAug 26, 2026 12:00 AM
Competition TypeICB
Funding SourceSelf-Funded
CountryUnited States
Address950 H Street, Nw,None,Washington,Dc-20223Contact Person: Willie Bethune,Erik Syfert,, Country:- United States of America
PublishedAug 24, 2026

Description

Onsite Drug Testing <p>The purpose of Amendment 1 is to upload the Q&A and the Attch 3 - Onsite Drug testing Provisions Clauses Rev 1.</p>

Full details are available after unlocking this tender.

Generated from Tender Access Hub · Aug 27, 2026 2:58 AM